Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC55

Azilsartanum medoxomilum

  • Status:
    Veitt
  • Application date:
    27.3.2012
  • Application published:
    15.4.2012
  • Grant published:
    15.4.2013
  • Max expiry date:
    6.12.2026
  • Medicine name:
    Edarbi og Ipreziv
  • Medicine for children:
    No

Timeline

Today
27.3.2012Application
15.4.2012Publication
15.4.2013Registration
6.12.2026Expires

Marketing license

  • IS authorization number:
    EU/1/11/734/001-011IS og EU/1/11/735/001-011IS
  • Date:
    7.12.2011
  • Foreign authorization number:
    EU/1/11/734/001-011 og EU/1/11/735/001-011
  • Date:
    7.12.2011

Owner

  • Name:
    Takeda Pharmaceutical Company Limited
  • Address:
    1-1, Doshomachi 4-chome Chuo-ku, Osaka-shi,Osaka JP

Agent

  • Name:
    Sigurjónsson & Thor ehf.
  • Address:
    Lágmúla 7, 108 Reykjavík

Patent

Annual fees

Number

Paid

Expires

Payer

Number: 1

Paid: 29.1.2025

Expires: 22.2.2026

Payer: Árnason Faktor ehf.

Number: 2

Paid: 13.2.2026

Expires: 6.12.2026

Payer: Árnason Faktor ehf.

Upload documents